Development and evaluation of Delta, a decision aid for parents and young people deciding whether or not to enrol in a paediatric oncology clinical trial

Not Applicable

Completed

• Conditions: Cancer; Cancer - Children's - Other; Public Health - Health promotion/education

• Registration Number: ACTRN12616000412437
• Lead Sponsor: Behavioural Sciences Unit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-31
• Study Completion: 2019-01-01
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 37

Inclusion Criteria

Parent/carers of children with cancer whose child:
a) is under 18 years of age
b) has been invited to participate in the Study 9 Phase III clinical trial.

Adolescents and young adults who have been diagnosed with cancer
a) is between 12 - 18 years of age
b) has been invited to participate in the Study 9 Phase III clinical trial.

All participants will be able to (i) give informed consent/assent; and (ii) read English.

Exclusion Criteria

a) AYAs and parents/carers who were not offered participation in a clinical trial by their treating team
b) Parents/carers with insufficient English to read the decision aid and complete questionnaires
c) Parents/carers of children who are deemed inappropriate to participate in the study by their treating oncologist due to poor psychological well-being or other psychiatric condition
d) Individuals not capable of providing fully informed consent due to any psychiatric or cognitive difficulties.

Study & Design

• Study Type: Observational
• Study Design: Not specified